Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer
The Gambro Polyflux HD-C4 Small Ease of Use Study
1 other identifier
observational
24
1 country
1
Brief Summary
The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2007
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 19, 2007
CompletedFirst Posted
Study publicly available on registry
December 21, 2007
CompletedMarch 11, 2025
March 1, 2025
1 month
December 19, 2007
March 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
For each dialyzer, the perceived ease of priming.
During priming of each dialyzer
Secondary Outcomes (1)
Visual assessment of residual blood in the dialyzer after rinse-back and if dialyzer clotted during treatment.
At the completion of each treatment
Interventions
Involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy.
Eligibility Criteria
The dialysis nursing staff will complete ease of use assessments following routine dialysis therapy of adult (≥ 18 years of age) patients
You may qualify if:
- n/a routine dialysis patients
You may not qualify if:
- n/a routine dialysis patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vantive Health LLClead
- Gambro Renal Products, Inc.collaborator
- Baxter Healthcare Corporationcollaborator
Study Sites (1)
Advanced Dialysis Center
Lanham, Maryland, 20706, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Rana Irmindra, M.D.
Advanced Dialysis Center
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2007
First Posted
December 21, 2007
Study Start
October 1, 2007
Primary Completion
November 1, 2007
Study Completion
November 1, 2007
Last Updated
March 11, 2025
Record last verified: 2025-03